Avatrombopag manufacturers and comparison of products from different manufacturers

Avatrombopag (Avatrombopag) is an oral thrombopoietin receptor agonist (TPO-RA), mainly used to treat thrombocytopenia associated with chronic liver disease (TCP) and to prevent the risk of bleeding caused by thrombocytopenia. Its mechanism of action is to simulate natural thrombopoietin (TPO) and selectively activate TPO receptors, thereby promoting bone marrow megakaryocyte proliferation and platelet production, and providing a non-transfusion treatment option for patients with thrombocytopenia.

Avatrombopag was originally developed by the United StatesDaiichi Sankyo (Daiichi Sankyo), and was approved for marketing by the United StatesFDA in2018 under the trade name Doptelet. The originator drug is available in oral tablet form and is suitable for patients with thrombocytopenia associated with chronic liver disease and those who require invasive surgery due to thrombocytopenia. Daiichi Sankyo supplies the drug to the international market through its global production base and distribution channels, ensuring the quality and traceability of the drug.

As the clinical demand for avatrombopag increases, generic drugs or licensed products have emerged in some regions. The ingredients of generic drugs are consistent with the active ingredients of the original drugs, and their efficacy and safety are basically comparable, but they may differ in excipients, tablet shape, dosage specifications or production processes. Compared with original drugs, generic drugs are usually cheaper and patients have more choices, but they need to ensure that they are purchased from regular channels to ensure drug quality and efficacy.

In clinical use, original drugs are usually recommended to special patients or high-risk groups that require precise dosage management due to their controllable quality, long time on the market, and abundant drug interaction and safety data. Generic drugs are suitable for patients with limited economic conditions or limited access to original drugs, but doctors still need to evaluate the patient's liver and kidney function, comorbid diseases, and past medication history before use. In addition, products from different manufacturers may have differences in tablet dosage specifications. Patients should strictly follow the doctor's prescription and drug instructions to ensure the therapeutic effect.

Reference materials:https://www.drugs.com/